Janelle Stoops
Marysville, Washington, United States
592 followers
500+ connections
About
I am a highly skilled process and analytical development scientist with more than 18…
Activity
-
Starting Day 2 with three (3) interesting activities - a panel discussion, and two standing room only roundtables. Chetan, Veerle, and I delved into…
Starting Day 2 with three (3) interesting activities - a panel discussion, and two standing room only roundtables. Chetan, Veerle, and I delved into…
Liked by Janelle Stoops
-
Our #OneSonoma team recently came together for an annual winter gathering, where we celebrated being a part of this fantastic team and reflected on…
Our #OneSonoma team recently came together for an annual winter gathering, where we celebrated being a part of this fantastic team and reflected on…
Liked by Janelle Stoops
-
Exciting opportunity! My team is hiring for an analytical development role in stem cell-based therapies. Join Lauren Jansen an amazing leader on my…
Exciting opportunity! My team is hiring for an analytical development role in stem cell-based therapies. Join Lauren Jansen an amazing leader on my…
Liked by Janelle Stoops
Experience
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Education
-
-
-
Member of the running start program, completing my AA degree along with my high school diploma.
Publications
-
Modulation of in vivo IgG crystallization in the secretory pathway by heavy chain isotype class switching and N-linked glycosylation
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
-
Russell body inducing threshold depends on the variable domain sequences of individual human IgG clones and the cellular protein homeostasis
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
More activity by Janelle
-
Join the WIB-Seattle digital booth during the 11 a.m. networking session at the "Career Evolution & Innovation in Biomanufacturing" event on…
Join the WIB-Seattle digital booth during the 11 a.m. networking session at the "Career Evolution & Innovation in Biomanufacturing" event on…
Liked by Janelle Stoops
-
Excited to attend the "Career Evolution & Innovation in Biomanufacturing" event on September 19th, 2024 hosted by…
Excited to attend the "Career Evolution & Innovation in Biomanufacturing" event on September 19th, 2024 hosted by…
Liked by Janelle Stoops
Other similar profiles
Explore more posts
-
Amanda Haupt
"San Diago... which of course in German means..." (you can fill in the blank in your head if you know the reference 😂) But I AM in gorgeous San Diego! Please reach out if you've been curious about base editing and would like to have an in person seminar in the So Cal region this month! Why base editing for your therapeutic cell engineering pipelines? ⏲️ SAVE TIME- reduce timelines on multiplex edited cell products by up to 90% 💰 SAVE ON COSTS of manufacturing when less steps are required to reach the end product 💪 HEALTHIER CELL PRODUCTS - gene editing with our platform avoids double strand DNA breaks, reducing the risk of genomic translocations, reducing cytotoxicity, and supporting normal growth rates
1 Comment -
Los Angeles Biotech Networks
Nuclein’s DASH® SARS-CoV-2 & Flu A/B Test for Use on the DASH® Rapid PCR System Receives FDA 510(k) Clearance and CLIA Waiver with Key Support from CovarsaDx® Research Team https://lnkd.in/ghCpGpNv LOS ANGELES, Jan. 7, 2025 /PRNewswire/ — CovarsaDx®, a prominent Clinical Research Organization (CRO) renowned for its in vitro diagnostics (IVDs) and medical device expertise, announced today that one of its clinical research study clients, [...]
-
Los Angeles Biotech Networks
Nuclein’s DASH® SARS-CoV-2 & Flu A/B Test for Use on the DASH® Rapid PCR System Receives FDA 510(k) Clearance and CLIA Waiver with Key Support from CovarsaDx® Research Team https://lnkd.in/ghCpGpNv LOS ANGELES, Jan. 7, 2025 /PRNewswire/ — CovarsaDx®, a prominent Clinical Research Organization (CRO) renowned for its in vitro diagnostics (IVDs) and medical device expertise, announced today that one of its clinical research study clients, [...] #LosAngeles #OrangeCountyCA #Biotech #Lifescience #News
-
Fintiede Solutions Ltd
🌟 Best of #ASMS2024 🌟 Fintiede Solutions is thrilled to share the groundbreaking advancements unveiled by Evosep at the #ASMS2024 conference in Anaheim! Evosep continues to push the boundaries in the field of proteomics, introducing innovations that are set to transform research and clinical diagnostics. 🔬 Key Innovations Announced: Fully Automated Workflows: - Capable of processing over 500 plasma samples per day. - Maximizes efficiency and minimizes manual intervention. - Ideal for accelerating drug discovery and supporting large-scale translational research. - Reduces cost per sample and environmental impact. Whisper™ Zoom Methods: - Enhances scalability and sensitivity for detailed and accurate proteomic analyses. - Unlocks the ability to detect low-abundant proteins and identify novel biomarkers. - Facilitates deeper biological insights into disease pathways. Evosep Biolabs: Center of Excellence for High Throughput Proteomics: - Specializes in high-throughput proteomics with automated sample preparation. - Offers access to state-of-the-art LC-MS/MS workflows and expert assay development. - Provides scalable capacity for outsourcing proteomics research projects. 🏆 Impact and Vision: Evosep's innovations are designed to make clinical proteomics 100x more robust and 10x faster, revolutionizing the landscape of proteomics research. These advancements are particularly aimed at accelerating drug discovery and enhancing proteomics-based diagnostics, ultimately improving patient care. We are proud to be part of this journey and look forward to the incredible breakthroughs these technologies will enable in the near future. #Evosep #Proteomics #ASMS2024 #ScientificInnovation #DrugDiscovery #TranslationalResearch #Biomarkers #ClinicalDiagnostics #automation #whisper
-
Los Angeles Biotech Networks
Aadi pulls commercial-to-preclinical pivot, buying ADCs and selling approved drug to reboot business https://lnkd.in/gEVjG72k Aadi Bioscience has rebooted its operations, transforming from a commercial business into a preclinical biotech by offloading its approved product and licensing antibody-drug conjugates (ADCs) for $44 million upfront. The Los Angeles-based company began looking for [...]
-
M. Stella Ritorto
https://lnkd.in/etB2Pmqt : a new compound called TRanscriptional Activator of p53 (TRAP-1) is able to engage p53-Y220C and BRD4 in a ternary complex, which potently re-activates mutant p53, resulting in rapid upregulation of p21 and other p53 target genes and inhibits the growth of p53Y220C-expressing cell lines.
-
Los Angeles Biotech Networks
#ASCO24: GenFleet highlights Phase 2 data on KRAS/EGFR combo in lung cancer https://lnkd.in/gCx3byzU As companies increasingly look to combinations to boost the efficacy of KRAS therapies, a Phase 2 study is offering some of the first clinical evidence for combining KRAS and EGFR in frontline lung cancer. On [...]
-
Biocom California
In this month’s Biocom California newsletter, leaders from BioMarin Pharmaceutical Inc., Takeda and Bayer join our Board of Governors, Gray Matter by Graymark Capital completes Westlake Labs life science building in Los Angeles’ Westlake Village community, MyoGene Bio receives Orphan Drug and Rare Pediatric Disease designations for its gene editing therapy for Duchenne muscular dystrophy, and more. Read the full edition here: https://bit.ly/40XGaLO
-
Los Angeles Biotech Networks
Under-the-skin Keytruda comparable to infused version in Phase 3 study, Merck says https://lnkd.in/gBu9dTGt An experimental under-the-skin injection of Merck & Co.’s cancer immunotherapy Keytruda showed similar characteristics as the current intravenous formulation in a Phase 3 clinical trial, the company said Tuesday. The drugmaker plans to discuss data [...] #LosAngeles #OrangeCountyCA #Biotech #Lifescience #News
-
Los Angeles Biotech Networks
StemCyte Announces Successful Phase IIa Clinical Trial Results for HPC, Cord Blood in Treating Post-COVID Syndrome: 85% of Patients Experience Complete Relief from Fatigue Symptoms https://lnkd.in/gXqDFKW2 BALDWIN PARK, Calif., Dec. 19, 2024 /PRNewswire/ — StemCyte announced a significant breakthrough in its Phase IIa clinical trial of HPC, Cord Blood (HPC, CB) for treating Post-COVID Syndrome (Long COVID). This trial results demonstrated [...]
-
Anthony Gallo
Imagine if you could turbocharge the speed of your flow cytometry analysis. 🤷 What if you could conduct your bench research the way you want to? Introducing the new Attune Xenith Flow Cytometer. The what if is here. Watch the full video: https://lnkd.in/gmms6wjU Experience the power of the Attune Xenith firsthand—request a demo today: https://lnkd.in/gZZeQPxt
-
Los Angeles Biotech Networks
Ambry Genetics Data Supports Functional Study of BRCA2, Helping Improve Variant Classification for Hereditary BRCA2-Linked Cancers https://lnkd.in/gBBxP8FM ALISO VIEJO, Calif.–(BUSINESS WIRE)–Ambry Genetics, a leader in clinical genomic testing, today announced its contribution to a study published in Nature that significantly advances our understanding of BRCA2 gene variants. As the uptake of genetic [...] #LosAngeles #OrangeCountyCA #Biotech #Lifescience #News
-
BioAnalysis, LLC
Lake N. Paul, PhD. is in San Diego at the Biotechnology Innovation Organization #BIO2024 conference meeting with colleagues & future clients. Connect with him in person to learn about how, as a Collaborative Research Organization, we are best positioned to support your analytical program. #aav #genetherapy #rarediseases #biophysics #STEM #STEMPhilly #biochemistry #celltherapy #bioanalysisllc #PhillyBusiness #phillyscience
-
Los Angeles Biotech Networks
Top stories from cell/gene therapy confab; 2032 deadline to decouple; Patient death in Pfizer trial; and more https://lnkd.in/gpNR9afR Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up [...] #LosAngeles #OrangeCountyCA #Biotech #Lifescience #News
-
LucidQuest
Thoughts on this? >> Gene therapy may cure rare diseases. But drugmakers have few incentives, leaving families desperate - Idaho State Journal >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #biotech #competitivemarketing #healthcare #pharma
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Janelle Stoops
-
Janelle Stoops
U.S. Director Team, Frontiers USA
-
Janelle Stoops
Individual care provider at Washington State Department of Commerce
2 others named Janelle Stoops are on LinkedIn
See others named Janelle Stoops